In the current issue:
-
Treatment of non small cell lung cancer.
Skřičková Jana et al. -
A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute.
Svoboda Marek et al.
Invited Article
Klin Onkol 2008; 21(6): 317-329.
Keywords: non-small-cell lung cancer, chemotherapy, radiotherapy, targeted therapy
Authors: Skřičková Jana, Čoupek Petr, Jakubíková Lenka, Tomíšková Marcela, Kaplanová Jana, Princ Denis, Kadlec Bohdan, Špelda Stanislav2008-12-15:Treatment of non small cell lung cancer.
Keywords: non-small-cell lung cancer, chemotherapy, radiotherapy, targeted therapy
Authors: Skřičková Jana, Čoupek Petr, Jakubíková Lenka, Tomíšková Marcela, Kaplanová Jana, Princ Denis, Kadlec Bohdan, Špelda Stanislav2008-12-15:Treatment of non small cell lung cancer.
Reviews
Klin Onkol 2008; 21(6): 330-337.
Keywords: neoadjuvant therapy, rectal adenocarcinomas, prognosis, biomarker, fluoropyrimidines, radiotherapy.
Authors: Garajová Ingrid, Svoboda Marek, Slabý Ondřej, Kocáková Ilona, Fabián Pavel, Kocák Ivo, Vyzula Rostislav2008-12-15:Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorythm
Keywords: neoadjuvant therapy, rectal adenocarcinomas, prognosis, biomarker, fluoropyrimidines, radiotherapy.
Authors: Garajová Ingrid, Svoboda Marek, Slabý Ondřej, Kocáková Ilona, Fabián Pavel, Kocák Ivo, Vyzula Rostislav2008-12-15:Possibilities of resistance prediction to neoadjuvant concomitant chemoradiotherapy in the treatment algorythm
Klin Onkol 2008; 21(6): 338-347.
Keywords: epidermal growth factor receptor, radiotherapy
Authors: Sirák Igor, Hátlová Jana, Petera Jiří, Vošmik Milan, Ryška Aleš, Vošmiková Hana2008-12-15:Epidermal growth factor receptor and radiotherapy.
Keywords: epidermal growth factor receptor, radiotherapy
Authors: Sirák Igor, Hátlová Jana, Petera Jiří, Vošmik Milan, Ryška Aleš, Vošmiková Hana2008-12-15:Epidermal growth factor receptor and radiotherapy.
Original articles
Klin Onkol 2008; 21(6): 348-358.
Keywords: metastatic breast cancer, trastuzumab, HER-2 gene, serum HER-2 protein, time to progression, overall survival, prognosis
Authors: Svoboda Marek, Grell Peter, Šimíčková Marta, Fabián Pavel, Petráková Katarína, Paacova Marketa, Macková Dagmar, Trojanec Radek, Hajdúch Marián, Pavlík Tomáš, Nenutil Rudolf, Vyzula Rostislav2008-12-15:A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute.
Keywords: metastatic breast cancer, trastuzumab, HER-2 gene, serum HER-2 protein, time to progression, overall survival, prognosis
Authors: Svoboda Marek, Grell Peter, Šimíčková Marta, Fabián Pavel, Petráková Katarína, Paacova Marketa, Macková Dagmar, Trojanec Radek, Hajdúch Marián, Pavlík Tomáš, Nenutil Rudolf, Vyzula Rostislav2008-12-15:A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute.
Information
Klin Onkol 2008; 21(6): 359.
2008-12-15:Information
2008-12-15:Information
Oncological association
Klin Onkol 2008; 21(6): 360.
2008-12-15:Oncological associations.
2008-12-15:Oncological associations.
